Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Formoterol fumarate (substance) |
Is a |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing budesonide and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Budesonide 80mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide 160mcg/formoterol 4.5mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide 320mcg/formoterol 9mcg dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Budesonide+eformoterol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide+eformoterol fumarate 200/6mcg bth-act dry pdr inh (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide+eformoterol fumarate 100/6mcg bth-act dry pdr inh (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Budesonide+eformoterol fumarate dihydrate 400micrograms/12micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Formoterol 20micrograms inhalation solution 2mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing formoterol and mometasone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing formoterol and glycopyrronium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing formoterol and glycopyrronium bromide in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Formoterol fumarate (substance) |
Is modification of (attribute) |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Formoterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing budesonide and formoterol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Budesonide and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Formoterol and mometasone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Budesonide and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
False |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aclidinium and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aclidinium and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aclidinium- and formoterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aclidinium and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Formoterol and tiotropium only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Formoterol and tiotropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Formoterol- and tiotropium-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing formoterol and tiotropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ciclesonide and formoterol and tiotropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ciclesonide- and formoterol- and tiotropium-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ciclesonide and formoterol and tiotropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ciclesonide and formoterol and tiotropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluticasone and formoterol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluticasone- and formoterol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing fluticasone and formoterol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Fluticasone and formoterol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Formoterol |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |